Denosumab-associated jaw bone necrosis in cancer patients: retrospective descriptive case series study
Abstract Background Denosumab (DMB) is a bone antiresorptive agent used to treat osteoporosis or metastatic cancer of the bones. However, denosumab-associated osteonecrosis of the jaw (DRONJ) has become a common complication in cancer patients. The prevalence of osteonecrosis of the jaw (ONJ) in can...
Saved in:
Main Authors: | Ji-Yeon Kang (Author), Sang-Yup Kim (Author), Jae-Seok Lim (Author), Jwa-Young Kim (Author), Ga-Youn Jin (Author), Yeon-Jung Lee (Author), Eun-Young Lee (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prediction models for early diagnosis of actinomycotic osteomyelitis of the jaw using machine learning techniques: a preliminary study
by: Sun-Gyu Choi, et al.
Published: (2022) -
Denosumab Related Osteonecrosis of the Jaw with Spontaneous Necrosis of the Soft Palate: Report of a Life Threatening Case
by: Mohammed Qaisi, et al.
Published: (2016) -
Case series: Osteonecrosis of the jaw related to denosumab preceded by bisphosphonates in cancer and osteoporotic patients
by: Devie Falinda, et al.
Published: (2022) -
DENOSUMAB-RELATED OSTEONECROSIS OF THE JAWS: A CASE REPORT
by: Milena Petkova, et al.
Published: (2017) -
Denosumab Related Osteonecrosis of Jaw: a Case Report
by: Marco Vinícius de Sales Lima, et al.
Published: (2018)